pharmaphorum

OCTOBER 15, 2020

The boom in digital tech over COVID means that pharma can move faster than ever – but the industry’s traditional processes for asset approval are still holding timelines back. David Reily examines how pharma companies are responding to the increased burden of asset approval with new ways of working. The coronavirus pandemic has forced a traditionally risk-averse industry tied to legacy systems for regulation and compliance to fully embrace digital solutions in commercial and marketing functions.

Communication 131

Communication People Management 131

Outsourcing Pharma

OCTOBER 12, 2020

Technology impacting generic drugs include artificial intelligence, telemedicine, fraud-preventing digital solutions and more, according to a report.

118

118

Pharma Marketing Network

OCTOBER 13, 2020

Below is a Q&A with Mark Bard, Co-Founder of The DHC Group, who offers his insights on the challenges COVID-19 has brought to pharma, as well as what innovation is taking place due to this full shift to digital and what lies ahead in the future. What is the most challenging aspect of COVID-19 for the industry? Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for v

Hospitals 105

Hospitals Communication Insurance 105

Pharma Times

OCTOBER 12, 2020

Two trials will involve over 6,000 participants at sites in and outside the US

54

54

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

OCTOBER 16, 2020

Patients with heart failure often have a dismal prognosis as the condition usually worsens over time, but a new study aims to see if digital health technologies can improve their prospects. The trial – run by Boehringer Ingelheim and Yale University – will test a smart bathroom scale device that has cardiac monitoring built in, as well as an app to help patients improve their diet and lose weight and a digital assistant designed to motivate them to actively manage their health.

Communication 121

Communication Hospitals 121

Outsourcing Pharma

OCTOBER 13, 2020

The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial.

105

105

Pharma Times

OCTOBER 12, 2020

Oral S1P receptor modulator hit both primary endpoints in a phase III trial

54

54

pharmaphorum

OCTOBER 13, 2020

Ayming Group’s second annual International Innovation Barometer (IIB) has said that the international outlook for R&D is “remarkably promising” despite strong headwinds caused by COVID-19. The report reveals that R&D departments are being empowered by the creation of ‘innovation ecosystems’, new funding methods, and the deployment of technology.

115

115

Outsourcing Pharma

OCTOBER 15, 2020

The pharmaceutical firmâs More to uS is a UK-centered campaign that shares stories of people living (and thriving) after a multiple sclerosis diagnosis.

79

79

Pharma Mirror

OCTOBER 14, 2020

Histoplasmosis is an inflammatory lung infection that usually occurs when a human has had contact with bird or bat droppings. Histoplasmosis is similar in symptoms to COVID-19, such as shortness of breath, fever, chest pain, and coughing. Some people who are at high-risk for histoplasmosis may also be concerned that they have contracted COVID-19. Though.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

OCTOBER 13, 2020

Biologic therapy hit primary and all key secondary endpoints in phase III

53

53

pharmaphorum

OCTOBER 16, 2020

In the age of artificial intelligence, no trial data should be going to waste. Findacure’s Rick Thompson looks at how these technologies could bring us closer to treatments for underserved rare diseases. The repurposing of drugs is becoming more common, especially in the field of rare diseases. In the past, repurposing has mostly been driven by academics looking for new possibilities in generics.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Immunization 105

Outsourcing Pharma

OCTOBER 14, 2020

The federal government continues to offer life-sciences professionals advice and resources as they pursue treatments to help fight the COVID-19 virus.

FDA 77

FDA 77

indispensable health

OCTOBER 12, 2020

Pre-Interview Tips for Pharmacy Professionals | Tip #3 with Tom Alig | Vice President of Staffing at Indispensable Health Hi, I am Tom Alig, VP of Staffing with Indispensable Health. I’ve been recruiting pharmacists and pharmacy technicians since 2004, and I’ve seen the things good candidates do to separate themselves, and I’ve seen the mistakes that some candidates make.

Customer Service 52

Customer Service 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

OCTOBER 15, 2020

Drug is licensed for secondary progressive multiple sclerosis with active disease

50

50

pharmaphorum

OCTOBER 14, 2020

A lack of clear information on COVID risk is stopping people with long-term conditions accessing the care they need – and could be storing up problems for the future. People living with long-term health conditions have been missing vital tests and monitoring because they fear contracting the novel coronavirus. A survey carried out by the Patient Information Forum (PIF), and supported by Norgine, this summer found that almost one in three respondents had delayed accessing care during the pandemic

Health and Personal Care Stores 105

Health and Personal Care Stores Communication Hospitals 105

Outsourcing Pharma

OCTOBER 12, 2020

Study solutions provider H? blends behavioral science, decision economics and technology to better integrate the patient voice into clinical research.

64

64

Med Ed 101

OCTOBER 14, 2020

This might be one of my biggest pet peeves. Adding a medication when we are already doing the opposite with another medication. I had a patient a while back who was taking cholestyramine twice daily for constipation. The patient and caregivers were unclear why the patient was on it but was noting that constipation was […]. The post Pet Peeve Alert: Can We Have a Constipation Medication?

40

40

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

OCTOBER 15, 2020

Review draws on experiences of patients and expert consensus

49

49

pharmaphorum

OCTOBER 13, 2020

UK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen to spearhead the next stage in the company’s development into gene silencing and other areas. Since it was founded in 2001 the company has become one of the country’s best known biotechs thanks to its approach to designing drugs based around network biology. e-therapeutics aims to design drugs that work across several targets that drive complex diseases and its remit has ch

100

100

Outsourcing Pharma

OCTOBER 14, 2020

The pharma ingredients company has named veteran Scott Thomson, a 29-year veteran with chemicals firm BASF, to its executive leadership team.

52

52

Med Ed 101

OCTOBER 11, 2020

Why do patients stop taking medications? I’ve spent a lot of time and effort working with patients to improve their drug therapy, but it really doesn’t matter if they don’t actually take the medication that is best for them. Here’s a list of the most common reasons that patients stop taking their medication(s). To be […]. The post Why Do Patients Stop Taking Medications?

40

40

Pharma Times

OCTOBER 13, 2020

The committee accepted a number of drugs through the PACE process

49

49

pharmaphorum

OCTOBER 16, 2020

Sanofi will shortly start human trials of a second coronavirus vaccine, developed with US biotech Translate Bio, after reporting that it stimulated antibodies against SARS-CoV-2 in preclinical testing. The French drugmaker’s Sanofi Pasteur vaccines division says it is planning a phase 1/2 trial of the mRNA-based vaccine, called MRT5500, before the end of the year.

Vaccines 98

Vaccines 98

Outsourcing Pharma

OCTOBER 13, 2020

The clinical research site network has tapped 22-year industry veteran Karri Venn, president of research with LMC Manna, to lead the organization.

52

52

Druggist

OCTOBER 13, 2020

It is estimated that around 103,800 of people live with HIV in the UK (PHE, 2019). Estimated 17% of people with HIV are not aware of the infection (NICE, 2016), increasing the risk of passing HIV when having sex without protection. Truvada (emtricitabine/tenofovir disoproxil) is an antiviral drug used in the treatment of HIV, alone or as part of antiviral combination therapy.

Community Pharmacies 98

Community Pharmacies Documentation 98

Pharma Times

OCTOBER 13, 2020

In a letter to Health Secretary Matt Hancock the RPS called for urgent action

49

49

pharmaphorum

OCTOBER 14, 2020

There is growing evidence that the coronavirus may be able to re-infect patients, and a new instance of a second infection has been confirmed in the US. . It is the fifth confirmed reinfection worldwide after at least four other cases were confirmed in Belgium, the Netherlands, Hong Kong and Ecuador. The latest case was recorded in the Lancet Infectious Diseases journal and involved a 25 year-old man with no known immune disorders or underlying conditions.

Immunization 98

Immunization Hospitals 98

Outsourcing Pharma

OCTOBER 13, 2020

Under the terms of the contract, Gilead will supply the EC with up to half a million treatment courses of Veklury to treat COVID-19 patients.

52

52

Druggist

OCTOBER 16, 2020

Several factors can impact breast milk supply with common factors including low frequency of breastfeeding, wrong latching by a baby, late start of breastfeeding, use of formula alongside breastfeeding and some drugs. Drug therapy to increase milk production is usually considered when insufficient milk is produced despite appropriate lactation support (Grzeskowiak et al, 2018).

Community Pharmacies 98

Community Pharmacies Dosage Hospitals 98

Pharma Times

OCTOBER 16, 2020

Latest reports highlights need for improved access to mental health care

49

49

pharmaphorum

OCTOBER 12, 2020

Gastroenterologist Dr Séverine Vermeire explains how lockdowns and communication changes over COVID-19 are taking their toll on ulcerative colitis patients and how we can best support them in the new normal. In an increasingly virtual healthcare world, the value of doctor to patient communication can’t be undervalued, especially in chronic conditions like ulcerative colitis.

Communication 88

Communication Hospitals Compounding 88

Outsourcing Pharma

OCTOBER 15, 2020

The company's Spectus and Percepta platforms offer features to help researchers meet challenges associated with working and collaborating in the pandemic.

43

43